The first successful case of heart transplantation in the city of Аlmaty: a one-year follow-up
https://doi.org/10.24412/2790-1289-2024-4-47-59
Abstract
According to the registry of the International Society of Heart and Lung Transplantation (ISHLT), approximately 5,000 heart transplantation are performed annually. Survival rates after heart transplantation are significantly higher compared to the natural course of terminal heart failure, as a result, transplantation activity has been increasing every year.
The article represents a clinical case of successful orthotopic biatrial heart transplantation to a recipient with end-stage heart failure, the peculiarity was the presence of a giant left atrium, the volume of which before the operation was 1070 ml, indexed volume 660 ml/m², long axis size 10.3 cm. Giant left atrium is a rare pathology characterized by excessive dilation of the cavity. According to literature data, the incidence of this pathology is 0.3%. Progressive left atrial dilatation was associated with the severe mitral regurgitation and atrial fibrillation in anamnesis. Description of the preoperative condition of the patient, features of surgical intervention and postoperative management of the patient. A dynamic assessment of the patient's condition was carried out throughout the year, including monitoring of laboratory parameters, instrumental investigations and functional tests.
About the Authors
R. M. TuleutaevKazakhstan
Tuleutaev Rustem Mukhtarovich – candidate of medical sciences, PhD, head of the department of cardiac surgery with a laboratory of artificial circulation and an operating unit
Almaty
M. O. Pashimov
Kazakhstan
Pashimov Marat Orumbasarovich – Candidate of Medical Sciences, Chairman of the Board
Almaty
S. B. Altybaeva
Kazakhstan
Altybaeva Saltanat Beisenalievna – cardiologist in the department of cardiac surgery with a laboratory of artificial circulation and an operating unit
Almaty
V. A. Mineeva
Kazakhstan
Mineeva Vildana Airatovna – second-year resident-cardiologist
Almaty
A. S. Madieva
Kazakhstan
Madieva Aigerim Sansyzbaykyzy – second-year cardiologist resident
Almaty
References
1. El Maghraby, A., & Hajar, R. (2012). Giant left atrium: A review. Heart Views, 13(2), 46-52. DOI: https://doi.org/10.4103/1995-705X.99227.
2. Khush, K. K., Hsich, E., Potena, L., Cherikh, W. S., Chambers, D. C., Harhay, M. O., et al. (2021). The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report – 2021; focus on recipient characteristics. The Journal of Heart and Lung Transplantation, 40(10), 1035. DOI: https://doi.org/10.1016/j.healun.2021.07.015.
3. Kittleson, M. M., Sharma, K., Brennan, D. C., Cheng, X. S., Chow, S. L., Colvin, M., et al. (2023). Dual-organ transplantation: Indications, evaluation, and outcomes for heart-kidney and heart-liver transplantation: A scientific statement from the American Heart Association. Circulation, 148(7). DOI: https://doi.org/10.1161/CIR.0000000000001155.
4. Global Observatory on Donation and Transplantation (2022). International report on organ donation and transplantation activities [Website]. Retrieved December 10, 2023, from https://www.transplant-observatory.org/
5. Darche, F. F., Helmschrott, M., Rahm, A. K., Thomas, D., Schweizer, P. A., Bruckner, T., et al. (2021). Atrial fibrillation before heart transplantation is a risk factor for post-transplant atrial fibrillation and mortality. ESC Heart Failure, 8(5), 4265-4277. DOI: https://doi.org/10.1002/ehf2.1355277.
6. Kosmacheva, E. D., Kizhvatova, N. V., Gordeeva, E. V., Bahchojan, M. R., Barbuhatti, K. O., Porhanov, V. A., & Aleksandrova, E. D. (2014). Oslozhnenija v posleoperacionnom periode u pacientov, perenesshih ortotopicheskuju transplantaciju serdca. Klinicheskaja medicina, 92(4), 30-34. (In Russian).
7. Velleca, A., Shullo, M. A., Dhital, K., Lyster, H., Peled, Y., & Reinhardt, Z. (2023). The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. The Journal of Heart and Lung Transplantation, 42(5), e1-e141. DOI: https://doi.org/10.1016/j.healun.2022.10.015.
8. Colvin, M., Smith, J. M., Ahn, Y., Israni, A. K., Snyder, J. J., & Kasiske, B. L. (2021). OPTN/ SRTR 2019 annual data report: Heart. Heart, 21(2), 356-440.
9. Chang, D. H., Youn, J. C., Dilibero, D., Patel, J. K., & Kobashigawa, J. A. (2021). Heart transplant immunosuppression strategies at Cedars-Sinai Medical Center. International Journal of Heart Failure, 3(1), 15-30. DOI: https://doi.org/10.36628/ijhf.2020.0034.
10. Nelson, J., Alvey, N., Bowman, L., Schulte, J., Segovia, M. C., McDermott, J., et al. (2022). Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation. Pharmacotherapy. Advance online publication, 42(8), 599-633. DOI: https://doi.org/10.1002/phar.2716.
11. Poz, J.A. L., Strokov, A. G., Kopylova, Ju. V., Popcov, V. N., Got'e, S. V. (2021). Zamestitel'naja pochechnaja terapija u recipientov serdechnogo transplantata. Transplantologija, 4, 62-72. DOI: https://doi.org/10.15825/1995-1191-2021-4-62-72. (In Russian).
12. Lund, L. H., Edwards, L. B., Dipchand, A. I., Goldfarb, S., Kucheryavaya, A. Y., Levvey, B. J., et al. (2016). The registry of the International Society for Heart and Lung Transplantation: Thirty-third adult heart transplantation report – 2016; focus theme: Primary diagnostic indications for transplant. The Journal of Heart and Lung Transplantation, 35(10), 1158-1169. DOI: https://doi.org/10.1016/j.healun.2016.08.017.
Review
For citations:
Tuleutaev R.M., Pashimov M.O., Altybaeva S.B., Mineeva V.A., Madieva A.S. The first successful case of heart transplantation in the city of Аlmaty: a one-year follow-up. Actual Problems of Theoretical and Clinical Medicine. 2024;(4):47-59. (In Russ.) https://doi.org/10.24412/2790-1289-2024-4-47-59